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Abstract
Background: It has been known that hypertension is an independent risk factor for cardiovascular disease (CVD).
CVD is the major cause of morbidity and mortality in developed and developing countries. Elevation of blood
pressure (BP) increases the adverse effect for cardiovascular outcomes. Prevention of increased BP plays a crucial
role in a reduction of those outcomes, leading to a decrease in mortality. Therefore, the purpose of this study was
to investigate the effects of dietary black sesame meal on BP and oxidative stress in individuals with
prehypertension.
Methods: Twenty-two women and eight men (aged 49.8 ± 6.6 years) with prehypertension were randomly
divided into two groups, 15 subjects per group. They ingested 2.52 g black sesame meal capsules or placebo
capsules each day for 4 weeks. Blood samples were obtained after overnight fasting for measurement of plasma
lipid, malondialdehyde (MDA) and vitamin E levels. Anthropometry, body composition and BP were measured
before and after 4-week administration of black sesame meal or a placebo.
Results: The results showed that 4-week administration of black sesame meal significantly decreased systolic BP
(129.3 ± 6.8 vs. 121.0 ± 9.0 mmHg, P < 0.05) and MDA level (1.8 ± 0.6 vs. 1.2 ± 0.6 μmol/L, P < 0.05), and increased
vitamin E level (29.4 ± 6.0 vs. 38.2 ± 7.8 μmol/L, P < 0.01). In the black sesame meal group, the change in SBP
tended to be positively related to the change in MDA (R = 0.50, P = 0.05), while the change in DBP was negatively
related to the change in vitamin E (R = -0.55, P < 0.05). There were no correlations between changes in BP and
oxidative stress in the control group.
Conclusions: These results suggest the possible antihypertensive effects of black sesame meal on improving
antioxidant status and decreasing oxidant stress. These data may imply a beneficial effect of black sesame meal on
prevention of CVD.
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Background
Hypertension is an important risk factor for cardiovascu-
lar disease (CVD) in developing countries. Elevation of
blood pressure (BP) is a risk factor for adverse cardiovas-
cular outcomes, including stroke, myocardial infarction,
renal failure and death [1]. Prevention of increased BP
therefore plays a crucial role in a reduction of those out-
comes. Impaired balance between relaxing and contract-
ing factors in the endothelium of blood vessels is an
important pathogenic mechanism of hypertension.
Increased pro-oxidant and decreased antioxidant activ-
ities have been shown to be some of the mechanisms of
the pathogenesis of hypertension [2].
It has been reported that sesame seeds can improve oxi-
dative stress due to actions of their contents of vitamin E
and lignans including sesamin, sesamolin and sesamol
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fits in relation to CVD by its antihypertensive effects
[8-11]. Although many previous studies have shown differ-
ent effects of vitamin E on BP [12-14], these studies inves-
tigated the effect of supplementation of either alpha-
tocopherol alone or mixed with gamma-tocopherol on BP
in diabetic [12,13] or hypertensive [14] patients who took
antihypertensive drugs. Interactions between alpha-toco-
pherol and the drug may diminish the antihypertensive
effect on BP [15]. Moreover, the dose of vitamin E in
those previous studies may have been so high that it
caused increased or unchanged effects on BP.
Interestingly, the antihypertensive effect of black
sesame (Sesamum indicum Linn.) meal, a product of
sesame oil manufacturing, does not seem to have been
previously investigated. Positive results may provide addi-
tional value to the manufactured product. Since we
wanted to examine preventive effects, we performed the
research on pre-hypertensive [16] healthy individuals
who did not take any medicine; hence the vitamin E
could exercise its antioxidant activity without interfer-
ence with any antihypertensive drug. Moreover, black
sesame meal contains gamma-tocopherol which was
reported to be lower in patients with coronary heart dis-
ease than control subjects [17]. Taken together with the
safety dose of vitamin E in black sesame meal in this
study [18], this may reveal an anti-hypertensive effect of
black sesame meal.
Based on knowledge of the effects of sesame seed and
lignans on oxidative stress, which is one of mechanisms of
the pathogenesis of hypertension [2], it was hypothesized
that black sesame meal may have an antihypertensive
effect in pre-hypertensive humans via improving antioxi-
dant status and decreasing oxidant stress. Therefore, the
aim of this study was to investigate the effects of 4-week
administration of black sesame meal on BP and oxidative
stress in pre-hypertensive humans.
Methods
Study design
A double-blind, placebo-controlled investigation was
undertaken. Subjects were divided into two groups, with
11 men and 4 women in each group, matched by age, BMI
and BP: a black sesame meal group (SG) (N = 15, aged
49.3 ± 7.7 years), and a placebo group (PG) (N = 15, aged
50.3 ± 5.6 years). Subjects and investigators were blinded
as to the composition of the black sesame meal and pla-
cebo capsules. After being screened by physical and blood
examination, all subjects were asked to complete health
questionnaires in order to provide health information
including cardiovascular risk factors. Subjects were seen
on two visits: before and after 4-week administration of
either black sesame meal capsules or placebo capsules.
During the 4 weeks, subjects were asked to take 6 capsules
each time, three times a day, with water after a meal. They
were asked to avoid vitamins and other dietary supple-
ments during the administration period. Subjects were
instructed not to change their diet and exercise routine
throughout the trial. At both visits, after a 12-h fasting
period, blood samples were collected to measure blood
parameters. Anthropometry (height, weight, and waist and
hip circumferences), body composition and BP were also
measured.
Subjects
Thirty middle-aged subjects (22 men and 8 women) were
recruited from the general population, supported by an
annual health checkup program performed at the Faculty
of Associated Medical Sciences, Khon Kaen University,
during 2008-2009. Subjects had no other diseases except
prehypertension as indicated either by systolic blood pres-
sure (SBP) from 120 to 139 mmHg or diastolic BP (DBP)
from 80 to 89 mmHg [16]. The patients were not currently
taking any medication or dietary supplementation that
affected BP. This study was conducted according to the
guidelines laid down in the Declaration of Helsinki, and all
procedures involving humans were approved by the Ethics
Committee of Khon Kaen University (HE 510254). Writ-
ten and verbal informed consent was obtained from all
subjects; verbal consent was witnessed and formally
recorded.
Power calculation
A change in SBP after the ingestion of black sesame
meal was used to calculate the sample size of this study
[9]. The magnitude of the change in SBP was 5 mmHg
for the power calculation. It was decided to require 90%
power at a significance level of 0.05. Thus, having at
least 15 subjects was required to finish this study.
Preparation of black sesame meal
The black sesame meal was prepared at the Faculty of
Pharmaceutical Sciences, Khon Kaen University, Thailand.
The sesame seeds were roasted before being pressed. The
remaining sesame meal was grounded into powder and
mixed with an adsorbent. This process is the same as that
used for commercial preparation. Each capsule of black
sesame meal was formulated to contain 0.42 g of black
sesame meal. The contents (mean ± SD) of carbohydrate,
protein and fiber of the black sesame meal were 46.37%,
21.57% and 14.12%, respectively. Moreover, sesamin and
sesamolin contents were 1.172 ± 0.002 mg/g DW and
0.605 ± 0.003 mg/g DW, respectively [19]. Total toco-
pherol was 105.41 ± 2.49 μg/g DW, mostly consisting of
gamma-tocopherol (102.78 ± 2.46 μg/g DW); alpha-toco-
pherol was not detectable [19]. The placebo capsule con-
tained the same contents, but without any black sesame
meal. Both capsules were the same shape and color.
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BP (mmHg) and heart rate (HR,/min) were measured in
the morning, after a 20-min rest, using an automatic
sphygmomanometer (Accurtorr 1A; Datascope, Japan)
on the right upper arm while the subject was in a sitting
position. Average BP and HR were calculated from three
measurements after an almost stable BP seemed to have
been reached. SBP and DBP were used to calculate
mean arterial pressure (MAP) by the formula: MAP =
DBP + 1/3 (SBP - DBP).
Measurement of malondialdehyde (MDA)
A plasma lipid peroxidation marker, MDA, was estimated
using thiobarbituric acid, as previously described [20]. In
brief, 150 μl of plasma was reacted with 125 μl 10% tri-
chloroacetic acid, 125 μl 5 mM ethylenediaminetetraace-
tic acid, 125 μl 8% sodium dodecyl sulfate, and 10 μl
0.5 μg/ml butylated hydroxytoluene. After vortexing vig-
orously for 30 s, the mixture was incubated for 10 min at
room temperature. Then 500 μl 0.6% thiobarbituric acid
was added, and the mixture was heated at 95°C for
30 min. After cooling to room temperature, the mixture
was centrifuged at 10,000 rpm for 10 min. The absor-
bance of the supernatant was measured at 532 nm using
a spectrophotometer (Genesys 20, SN: 35 gk 130009;
Thermo Fisher Scientific, USA). A standard curve was
generated with appropriate concentrations of 1,1,3,3-tet-
raethoxypropane standard (0.3-10 μmol/L); the plasma
MDA concentration was expressed as μmol/L of plasma.
Measurement of vitamin E
Serum vitamin E was determined using high performance
liquid chromatography (HPLC), according to the method
of Thurnham [21], by injection into a reversed-phase C-18
Spherisorb ODS2 column (diameter 5 μm, 4.6 × 100 mm;
Waters, USA). The mobile phase consisted of methanol/
acetonitrile/dichloromethane at a ratio of 4:4:1 with a flow
rate of 1 mL/min. A wavelength UV-visible detector
(model 2847, Waters) was set at a wavelength of 292 nm
for the detection of vitamin E. Quantification was based
on peak-height measurement, using the Clarity 2.2.0.67
software program, version C22 (DataApex, Czech
Republic).
Statistical analysis
All statistics were generated using Stata statistical soft-
ware, version 10 (StataCorp, USA). Data were expressed
as means ± SD. Changes in BP, MDA and vitamin E
levels between groups were compared by analysis of cov-
ariance (ANCOVA), with adjustment for baseline values.
The variables under study before and after the adminis-
tration within groups were compared by Student’sp a i r e d
t-test. The relationships between changes in oxidative
stress variables and BP were analyzed by Pearson’s
correlation. Statistical analyses were two-sided. If the sta-
tistical probability (P -value) was less than 0.05, the dif-
ferences were considered to be statistically significant.
Results
Baseline characteristics of subjects are shown in Table 1.
All subjects were pre-hypertensive individuals. No sig-
nificant differences in age, anthropometry, body compo-
sition, and levels of MDA and vitamin E, SBP, DBP,
MAP and HR were found between SG and PG groups.
In the SG group, after 4 weeks of administration of black
sesame meal, SBP was significantly decreased when com-
pared with before administration (121.0 ± 9.0 vs. 129.3 ±
6.8 mmHg, P < 0.05) (Figure 1A). Meanwhile, in the PG
group, SBP was slightly decreased after the placebo admin-
istration when compared with before administration
values (130.4 ± 4.8 vs. 130.6 ± 9.5 mmHg, P =0 . 5 2 ) .T h e
decrease in SBP in the SG group was significantly greater
than that in the PG group (P < 0.05) with adjustment for
baseline values. There were no apparent side effects
induced by black sesame meal throughout the study.
In the SG group, after 4 weeks of administration of
black sesame meal, DBP was decreased when compared
with before administration (72.8 ± 9.8 vs. 77.0 ± 7.4
mmHg, P = 0.20) (Figure 1B). Meanwhile, in the PG
group (85.9 ± 12.1 vs. 80.6 ± 7.7 mmHg, P = 0.14),
where the level was higher than before administration.
Table 1 Characteristics and baseline outcome of the
subjects at baseline
PG
(n = 15)
SG
(n = 15)
P-value
Age (yr) 50.3 ± 5.6 (39-58) 49.3 ± 7.7 (38-59) 0.70
Height (cm) 161.4 ± 5.4 (154-171) 159.5 ± 7.5 (150-173) 0.45
BW (kg) 66.9 ± 8.7 (53.9-78.5) 68.1 ± 12.1 (57.5-92.7) 0.71
BMI (kg/m
2) 25.6 ± 2.4 (21.8-29.1) 26.6 ± 3.2 (22.7-34.3) 0.29
%BF 31.5 ± 4.6 (24.7-37.6) 31.6 ± 3.4 (26.7-37.2) 0.92
FM (kg) 21.3 ± 5.1 (13.3-28.5) 21.7 ± 5.2 (15.9-32.7) 0.81
FFM (kg) 45.6 ± 4.7 (37.6-52.9) 46.4 ± 7.6 (37.7-60.9) 0.69
W (cm) 84.6 ± 6.9 (72-94) 85.8 ± 9.6 (74.5-107) 0.66
H (cm) 95.3 ± 4.9 (86-101.5) 96.9 ± 5.4 (88-108) 0.35
W/H ratio 0.89 ± 0.1 (0.77-0.94) 0.88 ± 0.1 (0.79-1.02) 0.75
MDA (μmol/L) 1.9 ± 0.62 (0.86-2.78) 1.8 ± 0.6 (1.19-2.81) 0.67
Vitamin E
(μmol/L)
26.5 ± 5.5 (17.2-34.4) 29.4 ± 6.0 (19.1-45.8) 0.18
SBP (mmHg) 130.4 ± 4.8 (127-138) 129.3 ± 6.8 (121-137) 0.43
DBP (mmHg) 80.6 ± 7.7 (72-99) 77.0 ± 7.4 (65-87) 0.63
MAP (mmHg) 97.2 ± 4.7 (90.3-108.7) 94.4 ± 6.1 (84.7-103.7) 0.51
HR (/min) 66.8 ± 7.4 (59-85) 68.7 ± 9.1 (53-93) 0.61
Values are expressed as means ± SD (minimum-maximum).
PG, placebo group; SG, black sesame meal group; BW, body weight; BMI, body
mass index; %BF, percentage of body fat; FM, fat mass; FFM, fat-free mass; W,
waist circumference; H, hip circumference; W/H ratio, waist and hip
circumference ratio; MDA, malondialdehyde; SBP, systolic blood pressure; DBP,
diastolic blood pressure; MAP, mean arterial pressure; HR, heart rate
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adjustment for baseline values were not significantly
different.
Moreover, there was no significant difference in
changes of average HR with adjustment for baseline
values in both PG and SG subjects (66.8 ± 7.4 and 68.7 ±
9.1/min before and 71.2 ± 11.1 and 71.4 ± 6.4/min after
4-week administration of black sesame meal and placebo,
P = 0.76).
Plasma MDA concentrations significantly decreased
after the 4-week administration of black sesame meal
when compared with before administration concentrations
(1.2 ± 0.6 vs. 1.8 ± 0.6 μmol/L, P <0 . 0 5 ) .T h e r ew e r en o
significant differences in MDA concentrations, however,
before and after 4-week administration of a placebo (1.8 ±
0.5 vs. 1.9 ± 0.6 μmol/L, P =N S ) .W h e nc o m p a r e dw i t h
the PG subjects, the SG subjects had significantly lower
plasma MDA concentrations after the 4-week administra-
tion with adjustment for baseline values (1.8 ± 0.5 (PG),
1.2 ± 0.6 (SG) μmol/L, P < 0.05) (Figure 2).
As shown in Figure 3, plasma vitamin E (total toco-
pherol) concentrations after 4-week administration of
black sesame meal were significantly increased when
compared with before administration concentrations
(38.2 ± 7.8 vs. 29.4 ± 6.0 μmol/L, P < 0.01). There were
no significant differences in vitamin E concentrations
before and after 4-week administration of the placebo
(29.8 ± 6.0 vs. 26.5 ± 5.5 μmol/L, P = NS). When com-
pared with the PG group, the SG group had significantly
greater plasma vitamin E concentrations after 4-week of
Figure 1 Average levels of SBP (A) and DBP (B) before and
after 4-week administration of black sesame meal and a
placebo in subjects with prehypertension. Values are expressed
as means ± SD. SBP, systolic blood pressure; DBP, diastolic blood
pressure; PG, placebo group; SG, black sesame meal group.
Figure 2 Plasma MDA concentrations before and after 4-week
administration of black sesame meal and a placebo in subjects
with prehypertension. Values are expressed as means ± SD. PG,
placebo group; SG, black sesame meal group; MDA,
malondialdehyde.
Figure 3 Plasma vitamin E concentrations before and after 4-
week administration of black sesame meal and a placebo in
subjects with prehypertension. Values are expressed as means ±
SD. PG, placebo group; SG, black sesame meal group.
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± 6.0 (PG), 38.2 ± 7.8 (SG) μmol/L, P < 0.01).
Only in the black sesame meal group did the change
in SBP tend to be positively related to the change in
MDA concentration (R = 0.50, P =0 . 0 5 ) ,w h i l et h e
change in DBP was negatively related to the change in
vitamin E concentration (R=0 . 5 5 ,P<0 . 0 5 ) .T h e r e
were no significant correlations between changes in BP
and oxidative stress indicators in the placebo group.
Discussion
This study appears to be the first to reveal the possible
antihypertensive effects of black sesame meal in partici-
pants with prehypertension. The results demonstrated that
after matching for age, BMI and BP, 4-week daily adminis-
tration of 2.52 g black sesame meal caused a significant
reduction in SBP, by an average of 8.2 mmHg.
Interestingly, the INTERSALT study revealed that a
reduction of 2 to 3 mmHg of SBP was associated with a
4% decrease in mortality from CVD in the USA and UK
[22] and a 6.4% decrease in mortality from cerebral vas-
cular disease in Japan [1]. Based on these longer term
studies, if the present reduction in BP with sesame meal
(8.2 mmHg) was sustained in the long term, this could
reduce the risk of CVD and stroke by 16.4% and 26.2%
respectively. This study shows that the ingestion of black
sesame meal may have a potential effect on reduction in
mortality from CVD and stroke.
Although no previous study has directly investigated the
effect of black sesame meal on BP, many studies have
reported the potential antihypertensive effect of sesame’s
contents (i.e. lignan and vitamin E) in humans and rats
[8-11,23]. However, this is inconsistent with many other
previous studies which reported different results [12-14].
Some previous studies have reported that supplementation
of either alpha-tocopherol alone or mixed with gamma-
tocopherol increased [12] or did not change [13] BP in dia-
betic or treated hypertensive patients [14]. This may be
attributed to an interference of alpha-tocopherol and the
antihypertensive drug taken by some subjects in previous
studies; whereas subjects in this study were healthy and
did not take any antihypertensive drug. Moreover, the dose
of vitamin E in those previous studies may have been so
high that it caused increased or unchanged effects on BP.
A possible mechanism responsible for the antihyper-
tensive effect of black sesame meal in this study may be
an improved balance between relaxing and contracting
factors in the endothelium of blood vessels. In this
study, black sesame meal may have enhanced the relax-
ing factor, resulting in improved endothelium-dependent
vasorelaxation in the pre-hypertensive participants relat-
ing to oxidative stress. The antihypertensive effect of
sesamin, in mildly hypertensive humans was supported
by a previous study [9]. The authors reported that the
ingestion of 60 g of sesamin per day for 4 weeks
decreased SBP by an average of 3.5 mmHg, and DBP by
1.9 mmHg [9]. Moreover, the increased plasma vitamin
E in this study may be due to the increased vitamin E
or the inhibition of catabolism of vitamin E. In addition,
bioavailability of vitamin E may be increased by interac-
tions between sesame lignan and tocopherols [24]. The
accumulation of vitamin E acts by detoxifying the
hydroxyl and proxy radicals, leading to reduced lipid
peroxidation, or by reducing excess tissue aldehydes
[11]. This is supported by many previous studies, in
which supplementation of either vitamin E or sesamin
and sesamolin demonstrated that these antioxidants
inhibit lipid peroxidation [3-7,25]. The antioxidant effect
is likely to contribute to the decreased endothelial dys-
function from free radicals [26], resulting in an increase
in the vasorelaxing factor, nitric oxide (NO) [27].
However, a mechanism that is not relevant to oxidative
stress cannot be ruled out. This was supported by a study
by Ward et al. (2004) which failed to show a link between
oxidative stress and BP [28]. It was shown that gamma-
tocopherol supplementation increased protein expression
of nitric oxide synthase [29], which stimulates vasorelaxa-
tion. Moreover, the potential effect of vitamin E on mem-
brane fluidity is likely to be another mechanism of
antihypertension. In vitro study, vitamin E was shown to
preserve endothelial cell (EC) migration in oxidized low-
density lipoprotein cells (oxLDL) and restore the endothe-
lial monolayer after injury by inhibiting changes in mem-
brane integrity caused by oxLDL [30]. A previous study in
rats demonstrated that antihypertensive rats had lower BP
than normotensive rats due to reduced membrane fluidity
after ingestion of vitamin E 3 d/week for 3 weeks [31].
These non-antioxidant properties of vitamin E could be
important in the prevention of atherosclerosis, resulting in
a reduction in BP in humans. Sesamin supplementation
also induced NO and inhibited endothelin-1 production by
EC [32]. These findings indicate an improved ability of the
endothelium to relax. In addition, a recent study has shown
that sesamin inhibited some CYP450 enzymes and the pro-
duction of 20-hydroxyeicosatetraenoic acid (20-HETE),
which might influence BP independently of any effects on
oxidative stress [33]. Moreover, sesamin increased Ca
2+
antagonistic vasorelaxing activity [34]. It should be empha-
sized in this discussion that these hypotheses are only on
the basis of the decrease in MDA and increased vitamin E,
because other possible mechanisms were not measured.
A limitation of this study is a lack of data on endothe-
lium-dependent vasorelaxation determined by NO and
other antioxidants such as vitamin C. Moreover, the
potential effect of vitamin E on membrane fluidity and
the ability of sesame lignans to inhibit 20-HETE synthesis
in human renal and liver microsomes were not investi-
gated by this study. Thus, further investigation of these
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meal on prevention of hypertension is needed. Impor-
tantly, having no discernible side effects from the inges-
tion of black sesame meal throughout this study implies
that it may be safe as a nutritional supplement for health
promotion.
Conclusions
This study suggests a beneficial effect of dietary black
sesame meal on a reduction in blood pressure in pre-
hypertensive humans. It is likely that the antihyperten-
sive effect is due to decreased oxidative stress. Taken
together with the absence of side effects and inexpensive
preparation, the regular ingestion of dietary black
sesame meal may be beneficial for CVD prevention in
individuals with prehypertension, or even those with
hypertension. A future study that investigates this
advantageous effect is suggested.
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